RIGEL PHARMACEUTICALS INC 4
4 · RIGEL PHARMACEUTICALS INC · Filed May 9, 2016
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-05-05+400,000→ 400,000 totalExercise: $2.54Exp: 2026-05-05→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the option vests one year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.